Zydus Cadila, a city-based pharmaceutical company, on Wednesday acquired 100 per cent stakes of Nippon Universal Pharmaceutical Ltd., a Japanese pharma company with its headquarters in Tokyo.
This is its second overseas acquisition, the first being Alpharma France in 2003.
The group has also recently moved into derma market in India valued at Rs 1500 crore, with the acquisition of Mumbai-based Liva Healthcare. At present, the company operates in 40 countries. This acquisition would provide the group with critcal access to a ready manufacturing and marketing base as well as a strong distribution reach in Japan.
Nippon reaches out to as many as 4,000 hospitals and clinics across the country. With the generics market valued at $3 billion stands at 5 per cent of the pharma market in Japan in terms of value, Chairman and Md Zydus Cadila Pankaj Patel said, “As the generic market in Japan is just opening up, post-2010 this market would be a major growth driver for global business of the company. The group has identified a new product development programme that will feed at least 5 to 6 products annually to portfolio and build a basket of 50 products over next four years.
Courtesy : Expressindia.com
This is its second overseas acquisition, the first being Alpharma France in 2003.
The group has also recently moved into derma market in India valued at Rs 1500 crore, with the acquisition of Mumbai-based Liva Healthcare. At present, the company operates in 40 countries. This acquisition would provide the group with critcal access to a ready manufacturing and marketing base as well as a strong distribution reach in Japan.
Nippon reaches out to as many as 4,000 hospitals and clinics across the country. With the generics market valued at $3 billion stands at 5 per cent of the pharma market in Japan in terms of value, Chairman and Md Zydus Cadila Pankaj Patel said, “As the generic market in Japan is just opening up, post-2010 this market would be a major growth driver for global business of the company. The group has identified a new product development programme that will feed at least 5 to 6 products annually to portfolio and build a basket of 50 products over next four years.
Courtesy : Expressindia.com